To evaluate the compliance of glaucoma patients to medical treatment and its impact on the intraocular pressure (IOP) and to verify the associated risk factors for noncompliance.
Methods:
All recruited patients were examined at the ophthalmology clinics of King Abdulaziz University Hospital, Riyadh, Saudi Arabia between May and August 2012. Patients were interviewed and subjected to answer a questionnaire that was developed based on a pilot test. Collected data included age, gender, number of prescribed drugs, and different reasons for noncompliance to the prescribed drugs.
Results:
Noncompliance was detected in 18 (19.4%) of the recruited patients. Factors associated with noncompliance demonstrated a trend toward older patients, males, patients with lower IOP at presentation, higher cup to disc ratio, and drug self-administering patients. However, the only statistically significant characteristic was being under lifelong medications (P = 0.005).
Conclusion:
Noncompliance was detected in around one-fifth of our glaucoma patients, particularly, the older group. Awareness programs, maintaining good patient–physician relationship, and personalizing treatment can lead to better adherence to treatment.
Get full access to this article
View all access options for this article.
References
1.
ResnikoffS., PascoliniD., Etya'aleD., et al.Global data on visual impairment in the year 2002. Bull. World Health Organ., 82:844–851, 2004.
2.
Al ObeidanS.A., DewedarA., OsmanE.A., and MousaA.The profile of glaucoma in a Tertiary Ophthalmic University Center in Riyadh, Saudi Arabia. Saudi J. Ophthalmol., 25:373–379, 2011.
3.
LeeD.A., and HigginbothamE.J.Glaucoma and its treatment: a review. Am. J. Health Syst. Pharm., 62:691–699, 2005.
4.
TsaiJ.C., McClureC.A., RamosS.E., SchlundtD.G., and PichertJ.W.Compliance barriers in glaucoma: a systematic classification. J. Glaucoma., 12:393–398, 2003.
5.
AshburnF.S.Jr., GoldbergI., and KassM.A.Compliance with ocular therapy. Surv. Ophthalmol., 24:237–248, 1980.
6.
SpaethG.L.Visual loss in a glaucoma clinic. I. Sociological considerations. Invest. Ophthalmol., 9:73–82, 1970.
7.
Van BuskirkE.M.The compliance factor. Am. J. Ophthalmol., 101:609–610, 1986.
8.
Newman-CaseyP.A., WeizerJ.S., HeislerM., LeeP.P., and SteinJ.D.Systematic review of educational interventions to improve glaucoma medication adherence. Semin. Ophthalmol., 28:191–201, 2013.
9.
DeokuleS., SadiqS., and ShahS.Chronic open angle glaucoma: patient awareness of the nature of the disease, topical medication, compliance and the prevalence of systemic symptoms. Ophthalmic Physiol. Opt., 24:9–15, 2004.
10.
LasterS.F., MartinJ.L., and FlemingJ.B.The effect of a medication alarm device on patient compliance with topical pilocarpine. J. Am. Optom. Assoc., 67:654–658, 1996.
11.
OlthoffC.M., SchoutenJ.S., van de BorneB.W., and WebersC.A.Noncompliance with ocular hypotensive treatment in patients with glaucoma or ocular hypertension an evidence-based review. Ophthalmology. 112:953–961, 2005.
12.
SleathB., BlalockS., CovertD., et al.The relationship between glaucoma medication adherence, eye drop technique, and visual field defect severity. Ophthalmology. 118:2398–2402, 2011.
13.
StewartW.C., ChorakR.P., HuntH.H., and SethuramanG.Factors associated with visual loss in patients with advanced glaucomatous changes in the optic nerve head. Am. J. Ophthalmol., 116:176–181, 1993.
14.
ZimmermanT.J., and ZaltaA.H.Facilitating patient compliance in glaucoma therapy. Surv Ophthalmol. 28Suppl:252–258, 1983.
15.
KassM.A., GordonM., and MeltzerD.W.Can ophthalmologists correctly identify patients defaulting from pilocarpine therapy?. Am. J. Ophthalmol., 101:524–530, 1986.
16.
RobinA., and GroverD.S.Compliance and adherence in glaucoma management. Indian J. Ophthalmol., 59Suppl. 1:S93–S96, 2011.
17.
ChaeB., Cakiner-EgilmezT., and DesaiM.Glaucoma medications. Insight. 38:5–9, 2013; quiz 10.
18.
MasoudM., Sharabi-NovA., and PikkelJ.Noncompliance with ocular hypertensive treatment in patients with primary open angle glaucoma among the Arab population in Israel: a cross-sectional descriptive study. J. Ophthalmol., 2013:405130, 2013.
19.
KhandekarR., Shama MelS., and MohammedA.J.Noncompliance with medical treatment among glaucoma patients in Oman—a cross-sectional descriptive study. Ophthalmic Epidemiol. 12:303–309, 2005.
20.
LaceyJ., CateH., and BroadwayD.C.Barriers to adherence with glaucoma medications: a qualitative research study. Eye (Lond). 23:924–932, 2009.
21.
FriedmanD.S., HahnS.R., GelbL., et al.Doctor-patient communication, health-related beliefs, and adherence in glaucoma results from the Glaucoma Adherence and Persistency Study. Ophthalmology. 115:1320–1327, 1327.e1321–e1323, 2008.
22.
GuptaR., PatilB., ShahB.M., et al.Evaluating eye drop instillation technique in glaucoma patients. J. Glaucoma., 21:189–192, 2012.
23.
JuzychM.S., RandhawaS., ShukairyA., et al.Functional health literacy in patients with glaucoma in urban settings. Arch. Ophthalmol., 126:718–724, 2008.
24.
MuirK.W., Santiago-TurlaC., StinnettS.S., et al.Health literacy and adherence to glaucoma therapy. Am. J. Ophthalmol., 142:223–226, 2006.
25.
GelbL., FriedmanD.S., QuigleyH.A., et al.Physician beliefs and behaviors related to glaucoma treatment adherence: the Glaucoma Adherence and Persistency Study. J. Glaucoma., 17:690–698, 2008.
26.
KholdebarinR., CampbellR.J., JinY.P., and BuysY.M.Multicenter study of compliance and drop administration in glaucoma. Can. J. Ophthalmol., 43:454–461, 2008.
27.
StoneJ.L., RobinA.L., NovackG.D., CovertD.W., and CagleG.D.An objective evaluation of eyedrop instillation in patients with glaucoma. Arch. Ophthalmol., 127:732–736, 2009.
